Cargando…

Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers

The arrival of targeted therapies has presented both a conceptual and a practical challenge in the treatment of patients with advanced non-small cell lung carcinomas (NSCLCs). The relationship of these treatments with specific histologies and predictive biomarkers has made the handling of biopsies t...

Descripción completa

Detalles Bibliográficos
Autores principales: Conde, E., Angulo, B., Izquierdo, E., Paz-Ares, L., Belda-Iniesta, C., Hidalgo, M., López-Ríos, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695315/
https://www.ncbi.nlm.nih.gov/pubmed/23359174
http://dx.doi.org/10.1007/s12094-012-0983-z